Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

NitroMed patent covers novel nitrosated H+/K+-ATPase inhibitors

March 12, 2004

Data reported from Viramidine phase II trial

March 10, 2004

ICE inhibitor pralnacasan prevents dextran sulfate sodium-induced colitis in mice

March 10, 2004

BMS describes novel, potent motilin agonist for treatment of GI hypomotility disorders

March 9, 2004

Micrologix presents nucleoside-based anti-HBV agents

March 8, 2004

Novel iNOS inhibitors for IBD, arthritis and pain designed at AstraZeneca

March 8, 2004

Clavulanate improves the efficacy of standard therapy for H. pylori infection

March 8, 2004

Novel class of HCV protease inhibitors evaluated by Lilly

March 5, 2004

H3 Pharma submits Sanvar IR NDA

March 4, 2004

Enrollment complete in phase IV Visicol constipation study

March 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...